Richard Bonneau

Genentech

The Research and Applied AI Summit (RAAIS) is a community for entrepreneurs and researchers who accelerate the science and applications of AI technology. In the lead up to our 7th annual event on June 23rd 2023 in London, we’re running a series of speaker profiles to shed more light on what you can expect to learn on the day!

Richard Bonneau leads Prescient Design, a molecular design accelerator at Genentech, a member of the Roche Group, that pioneers new methods for combining machine learning and molecular modeling. Dr. Bonneau’s research spans multiple levels of biological structure learning and modeling biological networks to predicting and designing macromolecular and biomimetic structure.  

Rich received his Ph.D. at the University of Washington, Seattle, where he pioneered new methods to predict biomolecular structure (Rosetta). At Genentech Research and Early Development (gRED), Bonneau and his team build new methods for applying machine learning to the design molecular composition, function and interfaces and in ways that span all drug modalities.